Cordis Announces Positive Results from Two Major Clinical Studies. Read More
Apr 24, 2025
Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients.
Read more
Jul 16, 2024
Jun 18, 2024
Nov 16, 2023
Nov 6, 2023
Cordis Announces Scott Drake as Chief Executive Officer
Oct 31, 2023
Oct 24, 2023
Cordis announces the completion of patient enrollment in SELUTION SLR™ DEB SUCCESS PTA Study
Oct 16, 2023
Oct 2, 2023